The Open Loop

Chay Carter

Neurotechnology is moving fast, but the real story is how it gets built, tested, funded, and scaled.   On The Open Loop, we explore the people, companies, and ideas shaping the future of neurotechnology, with honest conversations on what’s being built, what’s working, what’s difficult, and where the industry is really heading next.   Hosted by Chay Carter, Founder of Carter Sciences and Reccy Neuro, the podcast brings together founders, researchers, operators, investors, and industry leaders building at the intersection of neuroscience, healthcare, and technology.   Expect practical, unfiltered insight on: 🔹 Building neurotech companies from research to commercialisation 🔹 Brain-computer interfaces, neuromodulation, neuro-AI, and emerging technologies 🔹 Investment, regulation, and the realities of scaling in healthcare 🔹 The people, challenges, and decisions shaping the future of the industry   If you work in neurotechnology, neuroscience, healthcare innovation, or emerging technology, and want to understand what’s actually happening inside the industry, this is for you.

Épisodes

  1. Restoring Memory with BCIs - Dan Rizzuto

    -19 H

    Restoring Memory with BCIs - Dan Rizzuto

    In this episode of The Open Loop, Chay Carter is joined by Dan Rizzuto, President and CTO at Nia Therapeutics.   Dan shares how Nia is developing a closed-loop neurostimulation system designed to help patients with memory loss, combining implantable sensing, machine learning, wearable components, and personalised stimulation.   This is a practical conversation about the future of cognitive BCIs, what it takes to move neurotechnology from academic research into clinical development, and why memory restoration could become one of the most important frontiers in the field.   We also explore Nia’s FDA Breakthrough Device Designation for TBI-related memory loss, the evolution of BCI over the last 20 years, the reality behind cognitive enhancement hype, and why efficacy matters more than form factor when building neurotechnology for patients.   Key takeaways:   🔹 How Nia Therapeutics is developing closed-loop neurostimulation for memory loss 🔹 Why cognitive BCIs could become a major new category in neurotechnology 🔹 What FDA Breakthrough Device Designation means for clinical development 🔹 Why direct-to-consumer cognitive enhancement still needs stronger evidence 🔹 How the neurotech field is evolving from research breakthroughs to real patient impact Host: Chay Carter Founder, Carter Sciences Co-Founder, Reccy Neuro LinkedIn: https://www.linkedin.com/in/chay-carter/ Guest: Dr. Dan Rizzuto President and Chief Technology Officer at Nia Therapeutics LinkedIn: https://www.linkedin.com/in/rizzuto/ Key Chapters: 00:00 Introduction to Dan Rizzuto and Nia Therapeutics 02:23 Closed-Loop Neurostimulation for Memory Loss 05:09 From Motor BCIs to Cognitive Applications 09:40 How Nia’s Implantable and Wearable System Works 12:00 Cognitive Enhancement, Ethics, and Future Possibilities 14:09 FDA Breakthrough Device Designation and Regulatory Pathways 16:18 Fundraising, Clinical Trials, and What Comes Next 21:22 Emerging Modalities, Brain Data, and the Future of Neurotech   The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology.

    27 min
  2. The Future of Brain Medicine with Owen Muir

    13 MAI

    The Future of Brain Medicine with Owen Muir

    In the first episode of The Open Loop, Chay Carter, Founder of Carter Sciences and Reccy Neuro is joined by Dr. Owen Scott Muir, Interventional Psychiatrist, Co-founder & Chief Medical Officer at Radial.   Owen shares his personal journey through bipolar disorder, his experience as a clinical trial participant, and how those experiences shaped his mission to build the future of “brain medicine”.   This is a wide-ranging conversation on transcranial magnetic stimulation (TMS), neurotechnology, AI biomarkers, precision psychiatry, and what it really takes to scale brain-based treatments in the real world.   We also explore the future of neuromodulation, patient-centred care, and why Owen believes psychiatry is evolving into a much broader field of brain medicine.   Key takeaways:   🔸 How Owen’s personal experience with bipolar disorder led him into neurotechnology 🔸 Why TMS changed his view of mental health treatment 🔸 How AI biomarkers could help predict which treatments work for patients 🔸 Why Owen believes “mental health” should be reframed as “brain medicine” 🔸 What it takes to scale patient-centred neurotechnology in the real world   Host: Chay Carter Founder, Carter Sciences Co-Founder, Reccy Neuro LinkedIn: https://www.linkedin.com/in/chay-carter/   Guest: Dr. Owen Scott Muir MD, DFAACAP Interventional Psychiatrist Co-founder & Chief Medical Officer LinkedIn: https://www.linkedin.com/in/owen-muir-md-dfaacap-fctmss-53345b7/   Key Chapters: 00:00 Introduction to Dr. Owen Scott Muir 02:21 Personal Journey and Mental Health Experiences 05:57 Clinical Trials and the Future of Mental Health Treatment 09:49 Understanding Transcranial Magnetic Stimulation (TMS) 13:06 The Evolution of TMS Treatments 26:57 AI Biomarkers and Precision Psychiatry 35:58 Building a Patient-Centric Brain Medicine Company 46:22 The Future of Neurotechnology and Brain Medicine   The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology.   🔔 Subscribe for more conversations with the founders, researchers, and operators building the future of brain medicine.   #Neurotechnology #Neurotech #BrainMedicine #TMS #Neuromodulation #MentalHealth #PrecisionPsychiatry #AIHealthcare #BrainComputerInterface #Neuroscience #HealthcareInnovation #ClinicalResearch #DigitalHealth #TheOpenLoop #LifeScience #Podcast

    56 min

À propos

Neurotechnology is moving fast, but the real story is how it gets built, tested, funded, and scaled.   On The Open Loop, we explore the people, companies, and ideas shaping the future of neurotechnology, with honest conversations on what’s being built, what’s working, what’s difficult, and where the industry is really heading next.   Hosted by Chay Carter, Founder of Carter Sciences and Reccy Neuro, the podcast brings together founders, researchers, operators, investors, and industry leaders building at the intersection of neuroscience, healthcare, and technology.   Expect practical, unfiltered insight on: 🔹 Building neurotech companies from research to commercialisation 🔹 Brain-computer interfaces, neuromodulation, neuro-AI, and emerging technologies 🔹 Investment, regulation, and the realities of scaling in healthcare 🔹 The people, challenges, and decisions shaping the future of the industry   If you work in neurotechnology, neuroscience, healthcare innovation, or emerging technology, and want to understand what’s actually happening inside the industry, this is for you.